Literature DB >> 4214838

Serum 'uracil plus uridine' levels in normal subjects and their possible significance.

T E Parry, J A Blackmore.   

Abstract

A microbiological method for the assay of uracil is described. The growth of the test organism is supported by uracil and also by uridine but not by uridylic acid. The method therefore measures uracil and uridine together. The ;uracil + uridine' level, expressed as uracil, has been measured in blood from 144 normal subjects ranging in age from cord blood to the eighth decade. The mean level of 22 mu mol/l (0.25 mg%) in cord blood decreases to 15 mumol/l (0.17 mg%) in adults over the age of 20. There is no difference between the sexes. Uracil is of interest because (a) it is a constituent base of RNA, (b) it is the precursor of two of the bases thymine and cytosine that enter into the composition of DNA, and (c) under certain circumstances it has mutagenic properties. The last is dependent upon the existence of two tautomeric forms of uracil, the common keto form which pairs normally with adenine and the rare enol form which pairs with guanine. A mistake in base pairing which allows uracil in its enol form to enter the DNA molecule and pair with guanine can result in a G = C --> A = T base transition in the DNA molecule. The molecular mechanism involved as well as the possible bearing on somatic mutation are discussed.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4214838      PMCID: PMC475483          DOI: 10.1136/jcp.27.10.789

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  4 in total

1.  SOMATIC MUTATION AND CHRONIC DISEASE.

Authors:  M BURNET
Journal:  Br Med J       Date:  1965-02-06

2.  Mutation, autoimmunity, and ageing.

Authors:  A COMFORT
Journal:  Lancet       Date:  1963-07-20       Impact factor: 79.321

3.  On the molecular explanation of spontaneous and induced mutations.

Authors:  E FREESE
Journal:  Brookhaven Symp Biol       Date:  1959-11

4.  Microbiological assay of amino acids in serum: valine, leucine, and methionine.

Authors:  J A Blackmore; T E Parry
Journal:  J Clin Pathol       Date:  1972-02       Impact factor: 3.411

  4 in total
  5 in total

1.  F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase.

Authors:  Jason D Oliver; Graham E M Sibley; Nicola Beckmann; Katharine S Dobb; Martin J Slater; Laura McEntee; Saskia du Pré; Joanne Livermore; Michael J Bromley; Nathan P Wiederhold; William W Hope; Anthony J Kennedy; Derek Law; Mike Birch
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-25       Impact factor: 11.205

2.  Stimulation of the phosphorylation of uridine in skeletal muscle by insulin and vanadate.

Authors:  N Haugaard; A Torbati; T Smithgall; G Wildey
Journal:  Mol Cell Biochem       Date:  1990-03-05       Impact factor: 3.396

Review 3.  Physiological concentrations of purines and pyrimidines.

Authors:  T W Traut
Journal:  Mol Cell Biochem       Date:  1994-11-09       Impact factor: 3.396

4.  Differences in incorporation of nucleic acid bases and nucleosides by various Mycoplasma and Acholeplasma species.

Authors:  R S McIvor; G E Kenny
Journal:  J Bacteriol       Date:  1978-08       Impact factor: 3.490

5.  Effect of uridine on cellular UTP and glycogen synthesis in skeletal muscle: stimulation of UTP formation by insulin.

Authors:  E S Haugaard; K B Frantz; N Haugaard
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.